Sodium Sulfacetamide and Sulfur

Manufacturer
Method Pharmaceuticals, LLC
Effective date
2026-02-12
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
7
Source
full-release
Hydrated at
2026-05-31 22:06:00

Label at a glance#

ProductSodium Sulfacetamide and Sulfur
Active ingredientSULFACETAMIDE SODIUM, SULFUR
Label structure9 sections

Dosage and administration

USE: Wash affected area once or twice daily, or as directed by your physician. Avoid contact with eyes or mucous membranes. Wet skin and liberally apply to areas to be cleansed, massage gently into skin for 10-20 seconds working into a full lather, rinse thoroughly and pat dry. If drying occurs, it may be controlled by rinsing cleanser off sooner or using less often. See label booklet for Full Prescribing Informat...

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx Only

DESCRIPTION

DESCRIPTION SECTION

Each gram of sodium sulfacetamide 10% and sulfur 5% cleanser contains

100 mg of sodium sulfacetamide and 50 mg of sulfur in a cleanser

containing Aloe Vera leaf Extract, Butylated Hydroxytoluene, Cetyl Alcohol,

Citric Acid, Cocamidopropyl Betaine, Disodium EDTA, Glycerin, Glyceryl

Stearate SE, PEG-100 Stearate, Phenoxyethanol, Purified Water, Sodium

laureth sulfate, Sodium Thiosulfate, Stearyl alcohol, Triacetin, Xanthan Gum.



Sodium sulfacetamide is a sulfonamide with antibacterial activity while sulfur acts as a keratolytic agent. Sodium sulfacetamide is C 8H 9N 2NaO 3S·H2O with molecular weight of 254.24. Chemically, it is N-[(4-aminophenyl)sulfonyl]-acetamide, monosodium salt, monohydrate.

The structural formula is:

descdesc

CLINICAL PHARMACOLOGY

CLINICAL PHARMACOLOGY SECTION

The most widely accepted mechanism of action of sulfonamides is the Woods-Fildes theory, which is based on the fact that sulfonamides act as competitive antagonists to para-aminobenzoic acid (PABA), an essential component for bacterial growth. While absorption through intact skin has not been determined, sodium sulfacetamide is readily absorbed from the gastrointestinal tract when taken orally and excreted in the urine, largely unchanged. The biological half-life has variously been reported as 7 to 12.8 hours.
The exact mode of action of sulfur in the treatment of acne is unknown, but it has been reported that it inhibits the growth of Propionibacterium acnes and the formation of free fatty acids.

INDICATIONS

INDICATIONS & USAGE SECTION

SODIUM SULFACETAMIDE 10% - SULFUR 5% CLEANSER is indicated for use in the topical control of acne vulgaris, acne rosacea and seborrheic dermatitis.

CONTRAINDICATIONS:

CONTRAINDICATIONS SECTION

Sodium Sulfacetamide 10% & Sulfur 5% Cleanser is contraindicated in persons with know or suspected hypersensitivity to
sulfonamides, sulfur or any other component of this preparation. Sodium
Sulfacetamide 10% & Sulfur 5% Cleanser is not to be used by patients with
kidney disease.

WARNINGS

WARNINGS SECTION

Although rare, sensitivity to sodium sulfacetamide may occur. Therefore, caution and careful supervision should be observed when prescribing this drug for patients who may be prone to hypersensitivity to topical sulfonamides. Systemic toxic reactions such as agranulocytosis, acute hemolytic anemia, purpura hemorrhagica, drug fever, jaundice and contact dermatitis indicate hypersensitivity to sulfonamides. Particular caution should be employed if areas of denuded or abraded skin are involved.
Sulfonamides are known to cause Stevens-Johnson syndrome in hypersensitive individuals. Stevens-Johnson syndrome also has been reported following the use of sodium sulfacetamide topically. Cases of drug induced systemic lupus erythematosus from topical sulfacetamide also have been reported. In one of these cases, there was a fatal outcome. KEEP OUT OF REACH OF CHILDREN.

OTHER SAFETY INFORMATION

NOTICE: Protect from freezing and excessive heat. The product may tend to
darken slightly on storage. Slight discoloration does not impair the efficacy
or safety of the product. Keep bottle tightly closed.


Occasionally, a slight discoloration of fabric may occur when an excessive
amount of the product is used and comes in contact with white fabrics.
This discoloration, however, presents no problem, as it is readily removed
by ordinary laundering without bleaches.

DOSAGE AND ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

USE: Wash affected area once or twice daily, or as
directed by your physician. Avoid contact with eyes or mucous membranes.
Wet skin and liberally apply to areas to be cleansed, massage gently into
skin for 10-20 seconds working into a full lather, rinse thoroughly and pat
dry. If drying occurs, it may be controlled by rinsing cleanser off sooner or
using less often. See label booklet for Full Prescribing Information.
FOR EXTERNAL USE ONLY. NOT FOR INTRAVAGINAL OR OPHTHALMIC
USE. (KEEP AWAY FROM EYES).
KEEP OUT OF REACH OF CHILDREN.

Package Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

label1label1

label2label2

label3label3

label4label4

label5label5

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapPSN7
999613sulfacetamide sodium 100 MG/ML / sulfur 50 MG/ML Medicated Liquid SoapSCD7
999613sulfacetamide sodium 10 % / sulfur 5 % Medicated Liquid SoapSY7
999613sulfacetamide sodium 10 % / sulfur 5 % Topical CleanserSY7

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
SULFACETAMIDE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130358657472085GTIN-13: 0358657472085
EAN-13: 0358657472085
GTIN-12: 358657472085
UPC-A: 358657472085
GTIN storage (14 digits): 00358657472085
label3.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828
0304b7d2-7a07-d53b-750f-36012ae6612eProduct name120140508
64c0cc7e-6478-3ca1-8cd7-9a1251d5a3f6Product name120140508
9ae74339-0a3d-82e9-5dd1-88bd2607bd6bProduct name120140508
e44e38a9-2d9e-b0e2-cce9-490554639f3dProduct name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
58657-472-06Sodium Sulfacetamide and Sulfur170 g in 1 BOTTLE, PLASTICLIQUID1707
58657-472-07Sodium Sulfacetamide and Sulfur170.3 g in 1 BOTTLE, PLASTICLIQUID170.37
58657-472-08Sodium Sulfacetamide and Sulfur227 g in 1 BOTTLE, PLASTICLIQUID2277
58657-472-12Sodium Sulfacetamide and Sulfur340 g in 1 BOTTLE, PLASTICLIQUID3407
58657-472-13Sodium Sulfacetamide and Sulfur340.2 g in 1 BOTTLE, PLASTICLIQUID340.27

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
58657-472-06GM - Gram58657-47286ede03c-4a3d-474a-9219-0dede91d90a612022-02-07
58657-472-07GM - Gram58657-472866470b9-748f-4a59-9812-ae3ea7257ad812022-02-07
58657-472-08GM - Gram58657-4728f8a7aec-3f6d-474d-bc73-76fc92a3bea212022-02-07
58657-472-12GM - Gram58657-4723370d370-b0c1-441a-ba95-5f20a87ce35312022-02-07
58657-472-13GM - Gram58657-4729604bea5-30f4-4332-9822-3b4037eb0c8912022-02-07

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 21 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
58657-47258657-472-06, 58657-472-07, 58657-472-12, 58657-472-13, 58657-472-08

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 18 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
62025-10-21monthly-update2026-06-03 17:43:22
52024-11-20full-release2026-05-31 21:18:04

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Sodium Sulfacetamide and SulfurSULFACETAMIDE SODIUM, SULFURMethod Pharmaceuticals, LLCd35a7764-f3c6-fd1b-e053-2a95a90a80362026-02-12WarningsExact identifier
ndc (package): 58657-472-06
ndc (package): 58657-472-13
ndc (package): 58657-472-12
ndc (package): 58657-472-07
ndc (package): 58657-472-08
ndc (product): 58657-472
ndc11 (package): 58657047207
ndc11 (package): 58657047212
ndc11 (package): 58657047208
ndc11 (package): 58657047213
ndc11 (package): 58657047206
spl id: 4aad4bb3-b1ea-af60-e063-6394a90aeece
spl set id: d35a7764-f3c6-fd1b-e053-2a95a90a8036

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.